chr2-165115491-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 5P and 5B. PS1_ModeratePP2PP3_ModerateBS1_SupportingBS2
The NM_006922.4(SCN3A):c.3478G>A(p.Glu1160Lys) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000248 in 1,613,490 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another nucleotide change resulting in same amino acid change has been previously reported as Likely pathogenicin UniProt.
Frequency
Consequence
NM_006922.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SCN3A | NM_006922.4 | c.3478G>A | p.Glu1160Lys | missense_variant | 19/28 | ENST00000283254.12 | NP_008853.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SCN3A | ENST00000283254.12 | c.3478G>A | p.Glu1160Lys | missense_variant | 19/28 | 1 | NM_006922.4 | ENSP00000283254 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000264 AC: 4AN: 151700Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000199 AC: 5AN: 251354Hom.: 0 AF XY: 0.0000294 AC XY: 4AN XY: 135848
GnomAD4 exome AF: 0.0000246 AC: 36AN: 1461790Hom.: 0 Cov.: 32 AF XY: 0.0000261 AC XY: 19AN XY: 727200
GnomAD4 genome AF: 0.0000264 AC: 4AN: 151700Hom.: 0 Cov.: 31 AF XY: 0.0000270 AC XY: 2AN XY: 74084
ClinVar
Submissions by phenotype
not provided Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Nov 24, 2023 | This sequence change replaces glutamic acid, which is acidic and polar, with lysine, which is basic and polar, at codon 1160 of the SCN3A protein (p.Glu1160Lys). This variant is present in population databases (rs377632429, gnomAD 0.01%). This missense change has been observed in individual(s) with focal epilepsy (PMID: 24157691). This variant is also known as p.E1111K. ClinVar contains an entry for this variant (Variation ID: 240709). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on SCN3A protein function. Experimental studies have shown that this missense change affects SCN3A function (PMID: 24157691). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Feb 01, 2021 | Reported previously, as E1111K due to the use of alternative nomenclature, in an individual with focal epilepsy; however, parental test results were not provided (Vanoye et al., 2014); Functional studies demonstrate that E1160K channels exhibit increased persistent current compared to WT channels suggesting impaired inactivation (Vanoye et al., 2014); In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; This variant is associated with the following publications: (PMID: 24157691, 29466837) - |
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 24, 2017 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at